Evidence map›Paper›PMID 36286057›Full record

ArticleCurrent issues in molecular biology2022

Targeting Natural Plant Metabolites for Hunting SARS-CoV-2 Omicron BA.1 Variant Inhibitors: Extraction, Molecular Docking, Molecular Dynamics, and Physicochemical Properties Study.

Heba Ali Hassan, Ahmed R Hassan, Eslam A R Mohamed, Ahmad Al-Khdhairawi, Hala E Taha, Hanan M El-Tantawy, Iman A M Abdel-Rahman, Ali E Raslan, Khaled S Allemailem, Ahmad Almatroudi and 6 more

Abstract read
In one paragraph

Article in Current issues in molecular biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Heba Ali HassanDepartment of Pharmacognosy, Faculty of Pharmacy, Sohag University, Sohag 82524, Egypt.ORCID 0000-0002-2631-5831
Ahmed R HassanMedicinal and Aromatic Plants Department, Desert Research Center, El-Matariya, Cairo 11753, Egypt.ORCID 0000-0002-1060-2326
Eslam A R MohamedDepartment of Chemistry, Faculty of Science, Minia University, Minia 61511, Egypt.ORCID 0000-0002-0314-0725
Ahmad Al-KhdhairawiDepartment of Biological Science and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, Bangi 43600, Selangor, Malaysia.ORCID 0000-0001-9626-6302
Hala E TahaMedicinal and Aromatic Plants Department, Desert Research Center, El-Matariya, Cairo 11753, Egypt.
Hanan M El-TantawyMedicinal and Aromatic Plants Department, Desert Research Center, El-Matariya, Cairo 11753, Egypt.
Iman A M Abdel-RahmanDepartment of Pharmacognosy, Faculty of Pharmacy, South Valley University, Qena 83523, Egypt.ORCID 0000-0002-2586-9023
Ali E RaslanDepartment of Pharmacognosy, Faculty of Pharmacy, Al-Azhar University, Assiut 71524, Egypt.ORCID 0000-0002-8567-3970
Khaled S AllemailemDepartment of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia.ORCID 0000-0002-6486-9835
Ahmad AlmatroudiDepartment of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia.ORCID 0000-0002-1491-6402
Faris AlrumaihiDepartment of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia.ORCID 0000-0002-0850-5500
Maha A AlshiekheidDepartment of Botany & Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Hafiz Muzzammel RehmanDepartment of Human Genetics and Molecular Biology, University of Health Sciences, Punjab 54600, Pakistan.ORCID 0000-0002-5281-3156
Mahmoud M AbdelhamidDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Azhar University, Assiut 71524, Egypt.
Islam M Abdel-RahmanDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Deraya University, New-Minia 61519, Egypt.ORCID 0000-0003-0621-0677
Ahmed E AllamDepartment of Pharmacognosy, Faculty of Pharmacy, Al-Azhar University, Assiut 71524, Egypt.ORCID 0000-0003-0286-581X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: SARS-CoV-2 Omicron BA.1 is the most common variation found in most countries and is responsible for 99% of cases in the United States. To overcome this challenge, there is an urgent need to discover effective inhibitors to prevent the emerging BA.1 variant. Natural products, particularly flavonoids, have had widespread success in reducing COVID-19 prevalence. (2) Methods: In the ongoing study, fifteen compounds were annotated from Echium angustifolium and peach (Prunus persica), which were computationally analyzed using various in silico techniques. Molecular docking calculations were performed for the identified phytochemicals to investigate their efficacy. Molecular dynamics (MD) simulations over 200 ns followed by molecular mechanics Poisson-Boltzmann surface area calculations (MM/PBSA) were performed to estimate the binding energy. Bioactivity was also calculated for the best components in terms of drug likeness and drug score. (3) Results: The data obtained from the molecular docking study demonstrated that five compounds exhibited remarkable potency, with docking scores greater than -9.0 kcal/mol. Among them, compounds

Indexed as

Echium angustifoliummolecular dockingmolecular dynamicspeach fruitsSARS-COV-2 Omicron

Identifiers

PMID36286057
PMCPMC9600405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.